The underlying neuropathology characteristic of AD precedes symptom onset by many years, with the accumulation of amyloid-beta (Aβ) plaques believed to occur 15–20 years in advance of clinical manifestation of the disease (4), followed by the aggregation of abnormally phosphorylated tau in neurofibrillary tangles. This evidence concerns the gene MAPT and Alzheimer disease.